Myocardial stunning following defibrillation threshold testing

Journal of Interventional Cardiac Electrophysiology

Volumn 19, Issue 3, 2007, Pages 213-216

  Mollerus, Michael ^a   Naslund, Leslee ^a  

^a Duluth Clinic   (United States)

Author keywords

Defibrillation threshold testing; Implantable cardioverter defibrillator; Myocardial stunning

Indexed keywords

ADULT; ARTICLE; CASE REPORT; DEFIBRILLATION; DEFIBRILLATOR; ECHOCARDIOGRAPHY; HUMAN; IMPLANTATION; MALE; PRIORITY JOURNAL; STUNNED HEART MUSCLE;

DEFIBRILLATORS, IMPLANTABLE; ECHOCARDIOGRAPHY; ELECTRIC COUNTERSHOCK; HEART FAILURE; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; MYOCARDIAL STUNNING; MYOCARDIUM; TREATMENT OUTCOME; VENTRICULAR FIBRILLATION;

EID: 35348891358     PISSN: 1383875X     EISSN: 15728595     Source Type: Journal    
DOI: 10.1007/s10840-007-9150-9     Document Type: Article

References (25)

1. Pires, L. A., Lehmann, M. H., Steinman, R. T., Baga, J. J., & Schuger, C. D. (1999). Sudden death in implantable cardioverter-defibrillator recipients: Clinical context, arrhythmic events and device responses. Journal of the American College of Cardiology, 33, 24-32.
2. Mitchell, L. B., Pineda, E. A., Titus, J. L., & Bartosch, P. M. (2002). Sudden death in patients with implantable cardioverter defibrillators. Journal of the American College of Cardiology, 39, 1323-1328.
3. Kern, K. B., Hilwig, R. W., Rhee, K. H., & Berg, R. A. (1996). Myocardial dysfunction after resuscitation from cardiac arrest: An example of global myocardial stunning. Journal of the American College of Cardiology, 28, 232-240.
4. Klouche, K., Weil, M. H., Sun, S., Tang, W., Povoas, H. P., Kamohara, T., et al. (2002). Evolution of the stone heart after prolonged cardiac arrest. Chest, 122, 1006-1011.
5. DeAntonio, H. J., Kaul, S., & Lerman, B. B. (1990). Reversible myocardial depression in survivors of cardiac arrest. Pacing and Clinical Electrophysiology, 13, 982-985.
6. 2+ overload. Journal of Cardiovascular Electrophysiology, 13, 1017-1024.
7. Hurst, T. M., Hinrichs, M., Breidenbach, C., Katz, N., & Waldecker, B. (1999). Detection of myocardial injury during transvenous implantation of automatic cardioverter-defibrillators. Journal of the American College of Cardiology, 34, 402-408.
8. Schlüter, T., Baum, H., Plewan, A., & Neumeier, D. (2001). Effects of implantable cardioverter Defibrillator implantation and shock application on biochemical markers of myocardial damage. Clinical Chemistry, 47, 459-463.
9. Epstein, A. E., Kay, G. N., Plumb, V. J., Dailey, S. M., & Anderson, P. G. (1998). Gross and microscopic pathologic changes associated with nonthoracotomy implantable defibrillator leads. Circulation, 98, 1517-1524.
10. Schirmer, U., Hemmer, W., Lindner, K. H., Anhaupl, T., & Wieser T. (1997). Ultrastructural alterations in the right and left ventricular myocardium following multiple low energy endocardial countershocks in anesthetized dogs. Pacing and Clinical Electrophysiology, 20, 79-87.
11. Steinbeck, G., Dorwarth, U., Mattke, S., Hoffmann, E., Markewitz, A., Kaulbach, H., et al. (1994). Hemodynamic deterioration during ICD implant: Predictors of high-risk patients. American Heart Journal, 127, 1064-1067.
12. Runsiö, M., Bergfeldt, L., Brodin, L. Å., Ribeiro, A., Samuelsson, S., & Rosenqvist, M. (1997). Left ventricular function after repeated episodes of ventricular fibrillation and defibrillation assessed by transoesophageal echocardiography. European Heart Journal, 18, 124-131.
13. Poelaert, J., Jordaens, L., Visser, C. A., De Clerck, C., & Herregods, L. (1996). Transoesophageal echocardiographic evaluation of ventricular function during transvenous defibrillator implantation. Acta Anaesthesiologica Scandinavica, 40, 913-918.
14. Robin, J., Weinberg, K., Tiongson, J., Carnethon, M., Reddy, M., Ciaccio, C., et al. (2006). Renal dialysis as a risk factor for appropriate therapies and mortality in implantable cardioverter-defibrillator recipients. Heart Rhythm, 3, 1196-1201.
15. Cuculich, P. S., Sánchez, J. M., Kerzner, R., Greenberg, S. L., Sengupta, J., Chen, J., et al. (2007). Poor prognosis for patients with chronic kidney disease despite ICD therapy for the primary prevention of sudden death. Pacing and Clinical Electrophysiology, 30, 207-213.
16. Turakhia, M. P., Varosy, P. D., Lee, K., Tseng, Z. H., Lee, R., Badhwar, N., et al. (2007). Impact of renal function on survival in patients with implantable cardioverter-defibrillators. Pacing and Clinical Electrophysiology, 30, 377-384.
17. Joki, N., Hase, H., Saijyo, T., Tanaka, Y., Takahashi, Y., Ishikawa, H., et al. (2003). Combined assessment of cardiac systolic dysfunction and coronary atherosclerosis used to predict future cardiac deaths after starting hemodialysis. American Journal of Nephrology, 23, 458-465.
18. Paoletti, E., Specchia, C., Di Maio, G., Bellino, D., Damasio, B., Cassottana, P., et al. (2004). The worsening of LVH is the strongest predictor of SCD in HD patients: A 10 year survey. Nephrology Dialysis Transplantation, 19, 1829-1834.
19. Converse, R. L., Jacobsen, T. N., Toto, R. D., Jost, C. M., Cosentino, F., Fouad-Tarazi, F., et al. (1992). Sympathetic overactivity in patients with chronic renal failure. New England Journal of Medicine, 327, 1912-1918.
20. Aoki, J., Ikari, Y., Nakajima, H., Mori, M., Sugimoto, T., Hatori, M., et al. (2005). Clinical and pathologic characteristics of dilated cardiomyopathy in hemodialysis patients. Kidney International, 67, 333-340.
21. Landray, M. J., Wheeler, D. C., Lip, G. Y., Newman, D. J., Blann, A. D., McGlynn, F. J., et al. (2004). Inflammation, endothelial dysfunction, and platelet activation in patients with chronic kidney disease: The chronic renal impairment in Birmingham (CRIB) study. American Journal of Kidney Diseases, 43, 244-253.
22. Morales, M., Gremigni, C., Dattolo, P., Piacenti, M., Cerrai, T., Fazi, A., et al. (1998). Signal-averaged ECG abnormalities in haemodialysis patients. Nephrology Dialysis Transplantation, 13, 668-673.
23. Covic, A., Diaconita, M., Gusbeth-Tatomir, P., Covic, M., Botezan, A., Ungureanu, G., et al. (2002). Haemodialysis increases QT(c) interval but not QT(c) dispersion in ESRD patients without manifest cardiac disease. Nephrology Dialysis Transplantation, 17, 2170-2177.
24. Wong, C. K., Pun, K. K., Cheng, C. H., Lau, C. P., Leung, W. H., Chan, M. K., et al. (1990). Hypocalcemic heart failure in end-stage renal disease. American Journal of Nephrology, 10, 167-170.
25. Ghent, S., Judson, M. A., & Rosansky, S. J. (1994). Refractory hypotension associated with hypocalcemia and renal disease. American Journal of Kidney Diseases, 23, 430-432.